1.Liou KT., Shen YC., Chen CF., Taso CM., Tasi SK. The antiinflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol. 2003. 475:19–27.
Article
2.Teng CM., Chen CC., Ko FN., Lee LG., Huang TF., Chen YP, et al. Two antiplatelet agents from Magnolia officinalis. Thromb Res. 1988. 50:757–65.
3.Lo YC., Teng CM., Chen CF., Chen CC., Hong CY. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol. 1994. 47:549–53.
4.Tse AK., Wan CK., Shen XL., Yang M., Fong WF. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Biochem Pharmacol. 2005. 70:1443–57.
5.Fong WF., Tse AK., Poon KH., Wang C. Magnolol and honokiol enhance HL-60 lhuman leukemia cell differentiation induced by 1,25-dihydroxyviamin D3 and retinoic acid. Int J Biochem Cell Biol. 2005. 37:427–41.
6.Wang T., Chen F., Chen Z., Wu YF., Xu XL., Zheng S, et al. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol. 2004. 10:2205–8.
Article
7.Park EJ., Zhao YZ., Kim YH., Lee BH., Sohn DH. Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cell in vitro. Planta Med. 2005. 71:82–4.
8.Battle TE., Arbiser J., Frank DA. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005. 106:690–7.
Article
9.Bai X., Cerimele F., Ushio-Fukai M., Waqas M., Campbell PM., Govindarajan B, et al. Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003. 278:35501–7.
Article
10.Druckrey H., Preussman R., Ivanokovic S., Schmidt CH., Mennel HD., Stahl KW. Selective induction of bladder cancer in rats by dibutyl-and-N-butyl-N-butanol(4)-nitrosamine. Z Krebsforsch. 1964. 66:280–90.
11.Kim CS., Park S., Lee SB., Lee JM., Chung H., Chung MK, et al. The use of complementary and alternative medicine in patients with a urological malignancy. Korean J Urol. 2006. 47.
Article
12.Kalman DS., Feldman S., Feldman R., Schwartz HI., Krieger DR., Garrison R. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J. 2008. 7:11.
Article
13.Nagase H., Ikeda K., Sakai Y. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med. 2001. 67:705–8.
14.Kim YK. Bladder cancer: basic research direction. 1st ed.Seoul: Korea Medical Publishing Co;1991. 208-46.
15.Ito N., Makiura S., Yokota Y., Kamamoto Y., Hiasa Y. Effect of unilateral ureter ligation on development of tumors in the urinary system of rats treated with N-butyl-N-(4-hydroxy butyl) nitrosamine. Gann. 1971. 62:359–65.
16.Becci P., Thompson HJ., Strum JM., Brown CC., Sporn MB., Moon RC. N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder cancer in C57 BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res. 1981. 41:927–32.